Trial
NCT03551522
A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Gilead Sciences
Collaborators
—
Condition
NASH - Nonalcoholic Steatohepatitis
Intervention
Seladelpar
Why stopped
unexpected histological findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-15